William S. Harris, a Senior Scientist with Health Diagnostic Laboratory, Inc. (HDL, Inc.), will present Fish Oil Supplementation in Post-Myocardial Infarction Patients in the Triumph Study: Defining Characteristics and Relations with Two-Year Mortality at the American College of Cardiology’s Annual Scientific Sessions (ACC.13).
The poster session will be held in Expo North on Saturday, March 9th from 10:00 a.m.-10:45 a.m. at the Moscone Center in San Francisco.
As a recipient of five NIH grants for studies on the effects of omega-3 fatty acids on human health, Dr. Harris has more than 150 publications relating to omega-3 fatty acids in medical literature and was an author on two American Heart Association scientific statements on fatty acids: “Fish Consumption, Fish Oil, Omega-3 Fatty Acids and Cardiovascular Disease” (2002), and “Omega-6 Fatty Acids and Risk for Cardiovascular Disease” (2009,) both published in the journal Circulation. In 2009, Dr. Harris founded OmegaQuant, LLC, to offer the test to researchers, clinicians and the public, and his HS-Omega-3 Index technology was acquired by HDL, Inc., and now performed for medical clients. Dr. Harris is also a Professor at the University of South Dakota’s Sanford School of Medicine.
Szilard Voros, Chief Academic Officer, will present A Previously Validated Peripheral Blood Gene Expression Score Is Primarily Influenced by Plaque Burden, Rather than Ischemia, in 371 Patients from the COMPASS Multi-Center Study at the American College of Cardiology’s Annual Scientific Sessions (ACC.13).
The poster session will be held in Expo North on Sunday, March 10th from 3:45 p.m. to 4:30 p.m. at the Moscone Center in San Francisco.
A graduate of University Medical School of Pecs in Hungary, Dr. Voros completed his internal medicine internship and residency at the University of Alabama at Birmingham and has served in a variety of scientific and executive roles at the Piedmont Heart Institute. He serves as HDL, Inc.’s Chief Academic Officer and CEO of Global Genomics Group, LLC, and is a Clinical Associate Professor of Medicine, Cardiology, and Radiology at Stony Brook University in New York. Dr. Voros is a founding member of the Society for Cardiovascular Computed Tomography (SCCT), is a member of the Society for Cardiovascular Magnetic Resonance (SCMR), fellow of the American College of Cardiology, and fellow of the American Heart Association and Vice President of the Society of Atherosclerosis Imaging and Prevention.
Health Diagnostic Laboratory, Inc. (HDL, Inc.) is pleased to announce the formation of a strategic alliance with Global Genomics Group (G3), which aims to detect human susceptibility to cardiovascular disease through the discovery of genetic biomarkers. G3 and HDL, Inc. will create a new scientific process that uses advanced imaging to measure biological information.
Global Genomics Group, founded by Szilard Voros, MD, FACC, FSCCT, FAHA; Idean Marvasty; and Brad Brown, MS, has placed itself in the center of the realm of cardiac biomarkers—one of the fastest growing areas of the clinical diagnostic market. G3 is a privately held life sciences company focused on a mission to discover “novel therapeutic and diagnostic targets for atherosclerotic disease.”
“We focus our research around how human genetic variation affects heart disease risk. Our solution is to tie the use of advanced imaging to genetics and genomics—which will lead to more telling and innovative discoveries for the cardiovascular therapeutic market,” said Voros, G3’s CEO and co-founder.
Major pharmaceutical companies are shifting their research and development focus and are partnering with private sector companies such as G3 to help create innovation and target discovery in the area of cardiovascular therapies for the pharmaceutical industry.
“HDL, Inc.’s strategic joint venture with Global Genomics Group is inspiring,” said Tonya Mallory, CEO and co-founder of HDL, Inc. “Together, we will increase innovation and discoveries at HDL, Inc. and be able to impact and save more patients’ lives.”
Health Diagnostic Laboratory, Inc. to be the Presenting Sponsor at the 2012 Richmond Area
Step Out: Walk to STOP Diabetes
Richmond, VA – Health Diagnostic Laboratory, Inc. (HDL, Inc.), will be the Presenting Sponsor of the October 13, 2012 American Diabetes Association’s Step Out: Walk to STOP Diabetes. This annual event is the largest fundraiser of the year for the ADA.
The 5K Walk will begin at Bon Secours St. Mary’s Hospital. Registration is open at www.diabetes.org/stepoutrichmond. All of the money raised at this event goes toward funding research to find a cure and for educational programs in the Richmond community. Last year’s walk raised $225,000, with participation from more than 1,000 walkers.
Individuals as well as teams are welcome. Sponsorships are still available. In addition to the generous sponsorship of HDL, Inc., the following Richmond area companies/businesses are also sponsoring the Walk: AmerisourceBergen, LeClairRyan, Supervalu, VCU Medical Center, and Woody Funeral Home. Massage Envy, Novo Nordisk, Good Neighbor Pharmacy and Zacharias-Ganey, among others will participate in the Wellness Village.
“We are grateful for Health Diagnostic Laboratory’s generosity, and are thrilled that it will bring the same dynamism to our Walk that it employs in its labs. The ADA and Health Diagnostic Laboratory are both engaged in cutting-edge work to help the everyday lives of diabetics in our community and our country. The partnership between the two organizations is natural and will unequivocally further the ADA’s mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes,” said Rhodes B. Ritenour, Chairman of the Leadership Board of the American Diabetes Association in Central Virginia.
For more information on participating as a walker or a sponsor, contact Nancy Castrina at the Central Virginia ADA office at 804.225.8038, ext. 3287
About the American Diabetes Association
The American Diabetes Association is the nation’s leading voluntary health organization concerned with diabetes and its complications. Founded in 1940, the ADA provides services in communities nationwide. The mission of the American Diabetes Association is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
For more information visit their website, www.diabetes.org or call 1-800-DIABETES.
About Health Diagnostic Laboratory, Inc.
Health Diagnostic Laboratory, Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases. Their systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients. As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Health Coaches at no additional cost, improving compliance and enhancing satisfaction. For more information about HDL, Inc., please visit www.hdlabinc.com.